Infection of beagles with an opossum-derived strain of Trypanosoma cruzi (Tc-O) results in features of early and chronic chagasic cardiomyopathy, that is, increases in PR interval, atrioventricular block, and frequent ventricular premature contractions, ventricular tachycardia, and decreased left ventricular ejection fraction. These signs are not observed in animals infected with a canine strain of T. cruzi (Tc-D). To understand the biochemical basis for these early cardiac effects, we examined the P-adrenergic adenylate cyclase complex in myocardial membranes prepared from animals infected with either of the two strains. In animals infected with Tc-O (symptomatic), the maximum velocity (Vmax) decreased and concentration of agonist resulting in 50% of Vmax (Kact) increased for isoproterenol-dependent adenylate cyclase activity; in animals infected with Tc-D (asymptomatic), Vmax and K, for isoproterenol were unchanged from control, uninfected animals. 8-Receptor density decreased by 20% in symptomatic animals with no change in affinity, whereas no differences were observed between uninfected and infected asymptomatic animals. A complex pattern of changes was apparent in the guanine nucleotide binding protein, G,, in the setting of infection. Alterations in cholera toxindependent ADP-ribosylation patterns as well as immunochemical detection with anti-G., antisera suggested a change in the biochemical nature of the G, species and not necessarily a physical loss of this protein. Reconstitution of adenylate cyclase activity in cyc-membranes demonstrated a decrease in hormone-sensitive Gs activity in membranes prepared from symptomatic animals without a change in activity demonstrable in the presence of Gpp(NH)p. Collectively, the results suggest that the depression in ,t-adrenergic adenylate cyclase activity associated with symptomatic infection of beagles with T. cruzi occurs primarily as a result of changes in the G, protein complex, most likely resulting in an uncoupling of the /f-adrenergic receptor from the G, protein. (Circulation Research 1991;69:185-195) An outstanding characteristic of myocardial dysfunction in congestive heart failure is a decline in responsiveness to the inotropic and chronotropic actions of ,3-adrenergic catecholamines.' At a time when the failing heart has become increasingly dependent on adrenergic support to maintain its contractile state, responsiveness to the From the
obscuring their relative contribution to the expression of disease.
We recently have studied myocardial dysfunction in the setting of Chagas' disease in mice after infection of the host animal with the parasite Trypanosoma cruzi. 6 The results indicate that many features of this experimental model are shared in common with other cardiac diseases of microvascular etiology. For example, myocardial pathology in chagasic mice was remarkable for inflammation, fibrosis, and microvascular aneurysmal formation and dilation,7 features commonly observed in the congenital Syrian hamster model of congestive heart disease. Indeed, in both the Syrian hamster and mice infected with T. cruzi, concomitant verapamil administration prevented the expression of disease.8,9 More important, throughout the course of infection and associated cardiac manifestations of Chagas' disease in mice, we observed profound alterations in the 13-adrenergic adenylate cyclase complex, including a decrease in ,8-adrenergic receptor density and affinity, a decrease in agonist-dependent activation of adenylate cyclase activity, and a decrease in the magnitude of choleraand pertussis toxin-dependent ADP-ribosylation, a marker for the guanine nucleotide binding proteins that couple the receptor to the effector cyclase unit. 6 Similar changes have been observed in other models of cardiac dysfunction and congestive heart failure. 4, 5 Many of the changes in the ,B-adrenergic receptor complex predated the appearance of significant cardiac dysfunction, suggesting that such changes may have been important early participants in the development of congestive heart failure. However, the murine model of Chagas' disease does not permit accurate and subtle determinations of cardiac dysfunction during the development of Chagas' disease. To circumvent these limitations, in this report, we have used a canine model of Chagas' disease that includes an additional feature, namely, the use of a strain of T. cruzi that produces parasitemia but no apparent myocardial involvement. Thus, in addition to uninfected controls, we can contrast changes observed in asymptomatic and symptomatic infected animals and identify infection-versus disease-associated alterations in myocardial ,3-adrenergic adenylate cyclase activity. Furthermore, the model permitted us to evaluate a time point in the evolution of cardiac dysfunction in the absence of congestive heart failure, thereby permitting us to test the hypothesis that changes in the ,B-adrenergic receptor complex are important participants in the development of congestive heart failure per se. [3H]cyclic AMP (cAMP) were obtained from New England Nuclear-Dupont, Boston. Gpp(NH)p was obtained from Sigma Chemical Co., St. Louis. Cholera toxin was obtained from Schwartz Mann Laboratories, Cambridge, Mass. All other reagents were of the highest purity commercially available. Dogs Pure-bred beagles were purchased from Hazleton Research Products, Inc., Denver, Pa. A total of 12 bred beagles was used in the study (age, 15-40 weeks) . In each group to be studied, four animals served as controls, four animals were infected with the Tc-O strain of T. cruzi, and four animals were infected with the Tc-D strain of T. cruzi. Dogs were vaccinated as puppies against Bordetella, parainfluenza, parvovirus, distemper virus, hepatitis virus, rabies, and leptospirosis. They were dewormed regularly and had three consecutively negative fecal examinations before entering the study. Animals were housed singly in cages in the School of Veterinary Medicine Laboratory Animal Resource Facility for a 4-week acclimatization period before and during the study except for a period each day when they exercised in individual runs. They were fed a commercial dry dog chow.
Parasites and Infection
The T. cruzi isolates were recovered from a dog (Tc-D) and an opossum (Tc-O) and were maintained in our laboratory as previously described.'0 Trypomastigotes were maintained in and harvested from African green monkey kidney cells (Vero cells), washed three times in Eagle's minimum essential media (MEM; GIBCO, Grand Island, N.Y.), counted in a modified Neubraur hemocytometer, and resuspended to a concentration of 10' per milliliter in MEM. Dogs from each group were inoculated subcutaneously between the shoulder blades with 5 x 10' trypomastigotes per gram body weight up to a maximum dose of 2 x 10' organisms from either Tc-O or Tc-D, or with MEM (uninfected controls). The quantity of parasites inoculated and the age of the animal at which inoculation was performed were chosen after preliminary studies that indicated these conditions were associated with little or no mortality during the acute phase of the disease, that is, acute Chagas' disease, which occurs within 30 days of infection." Infected animals displayed similar humoral (antibody titers) and cellular (peripheral blood mononuclear cell blastogenesis responses) immune responses to infection.10
Moris et al Canine Cardiomyopathy and j3-Adrenergic Receptor Complex 187 ing system (model 79D, Grass Instruments Inc., Quincy, Mass.) was recorded before and approximately every 10 days after infection.14 Briefly, three bipolar standard leads (I, II, and III), three augmented unipolar limb leads (aVR, aVL, and aVF) and four unipolar precordial chest leads (CV5RL, CV6LL, CV6LU, and Vl0) were recorded. Nonsedated dogs were placed in right lateral recumbency, and needle electrodes were placed subcutaneously over the olecranon process of the elbow and the patella of the stifle of both legs. For each tracing, the voltage was standardized at 1 mV/cm and a paper speed of 50 mm/sec was used except for an extended lead II strip that was recorded at 25 mm/sec for the purpose of detecting intermittent arrhythmias. ECG measurements were made using standard methods as described previously. 12,000g . The pellet was resuspended in 1% trichloroacetic acid, recentrifuged at the same speed, and solubilized in "sample buffer" (10 mM Tris-HCl, 0.1% sodium dodecyl sulfate, 0.1% 2-mercaptoethanol, pH 6.8). Samples were boiled for 2 minutes. Electrophoresis was performed on vertical slab gels (main gel, 10%; stacking gel, 1.25% acrylamide) at 150 V for 2 hours. Gels were stained subsequently with Coomassie blue and analyzed by autoradiography. Intensity of bands corresponding to molecular weights of the G proteins of interest were determined spectrophotometrically as the optical density (OD/pixel) using Quantimet 970 (Cambridge Instruments, Inc., Cambridge, Mass.).6
Preparation of Gas Antisera and Performance of Western Blots
The antigen used to raise antisera contained a 16-amino acid sequence (Cys-Lys-Glu-Leu-Gln-LysAsp-Lys-Gln-Val-Tyr-Arg-Ala-Thr-His-Arg) unique to the Gas subunit of Gs (Peninsula Laboratories, Inc., San Carlos, Calif.). The polypeptide was conjugated to keyhole limpet hemocyanin (KLH) via the amino terminal cysteine residue of the polypeptides using m-maeimido-benzyol-N-hydroxysuccinimide ester as described. 23 The peptide-KLH conjugate was used to raise polyclonal, monospecific antisera in rabbits. A total of 100 ,gg peptide-KLH emulsified in complete Freund's adjuvant was injected intradermally at 15-20 sites on the rabbit and was followed by a booster injection of 50 gg peptide-KLH in incomplete Freund's adjuvant after 4 weeks. Sera from various rabbits were tested for binding to the antigen using an immunoblot technique, and those samples giving positive reaction at 1:500 dilution were used. Western blot analysis was performed after overnight transfer of proteins, run on sodium dodecyl sulfate-polyacrylamide gel electrophoresis (SDS-PAGE) and prepared as described above, to nitrocellulose in a buffer containing 20% methanol, glycine (150 mM), and Tris in simultaneous assays performed under identical reaction conditions, cholera toxin-dependent ADPribosylation of dog heart membranes occurred in a molecular weight region (42 kDa) completely superimposable with antibody binding. Third, our antisera recognized purified Gs obtained from rabbit liver as a single 42-kDa band. Finally, using Gas antisera 234725 (obtained from Dr. D. Manning, Department of Pharmacology, University of Pennsylvania Medical School, Philadelphia), we observed qualitatively identical binding patterns to dog heart membranes as observed using our own antisera.
Statistical Analysis and Significance
Biochemical and physiological assays were performed from one to three times on each individual animal or associated membrane preparation, and the data were pooled for each of the three groups (uninfected; infected asymptomatic, Tc-D; infected symptomatic, Tc-O). Within each group, the variation from one individual animal to the other with regard to all biochemical and physiological parameters under consideration was always less than 15% of the mean value obtained for the group as a whole. Intergroup variations were determined from the means and standard deviations of all relevant assays performed, and significance was determined using Student's t test as previously described.6
Determination of Na+,K+-ATPase Activity Determination of total, Na+,K+-ATPase, and
Mg2+-ATPase activity in membranes alone or in the presence of cholate was performed on membranes prepared as above and as previously reported.26
Results Our laboratory previously has described two isolates of T. cruzi, Tc-O and Tc-D, that produce different clinical responses when inoculated in the mouse. 27 The availability of these two strains provided us with the opportunity to distinguish infection with myocardial features (referred to as symptomatic) from infection in the absence of any overt cardiac signs (referred to as asymptomatic). Beagles inoculated with either Tc-O or Tc-D strains of T. cruzi displayed similar humoral (antibody titers) and cellular (peripheral blood mononuclear cell blastogenesis responses) immune responses to infection.10 Dogs infected with Tc-O developed acute myocarditis associated with increases in PR interval (Table 1) , atrioventricular block, depression of R wave amplitude, and shifts in the mean electrical axis by day 20 ADP-ribosylation by cholera toxin is a useful marker for the stimulatory guanine nucleotide binding protein (. As shown in Figure 4 , the magnitude of cholera toxin-catalyzed ADP-ribosylation in a 42-kDa band in uninfected and asymptomatic infected animals is essentially equal to, and slightly, but not significantly, increased in the presence of NADP. In contrast, cholera toxin-dependent ADP-ribosylation in membranes prepared from symptomatic infected animals was less than 50% of that observed in uninfected animals. Furthermore, unlike the modest increase in cholera toxin-dependent ADP-ribosylation observed in the presence of NADP in both control and infected asymptomatic animals (<20%), the presence of NADP permitted twice as much cholera toxin-dependent ADP ribosylation to occur in infected symptomatic animals.
To complement the cholera toxin-dependent ADP-ribosylation studies, we examined the putative G. coupling units more directly using rabbit antisera directed against specific amino acid sequences of GAs developed as described. 23 In a Western blot analysis of SDS-PAGE-treated myocardial membranes (Figure 5 ), the G,as antisera bound to a number of bands of molecular weight greater than 36 kDa in a manner FIGURE 5. Analysis of dog heart membrane proteins using anti-GCrs antisera: Influence of infection. Dog heart membranes from infected symptomatic (lanes 1-3) , infected asymptomatic (lanes 4-6), and uninfected animals (lanes 7-9) were incubated in ADP-ribosylation assay mxture without [32PINAD as described in "Materials and Methods," with no toxin or activators (lanes 1, 4, and 7), cholera toxin and Gpp(NH)p (1 pM) (lanes 2Z 5, and 8), or GTP-y-S (1 pM) and Mgt (5 mM) (lanes 3, 6, and 9) and were separated with sodium dodecyl sulfate-polyacrylamide gel electrophoresis in a manner identical to that used for results of Figure 4 . Western blot analysis of nitrocellulose blot transfers was performed as described, and anti-Ga,, antisera binding was detected using [ both common to all membrane preparations and specifically related to the state of the animal from which the membranes were prepared. We also examined the extent to which incubation of the dog heart membranes with cholera toxin or GTP-y-S and Mg', conditions associated with the activation and dissociation of Gas, might alter the level of antibody binding to the G,as subunit. Common to all membrane preparations, antisera binding occurred in molecular weight regions of 36, 42-45, and greater than 55 kDa.
Importantly, in the molecular weight regions greater than 55 kDa, the intensity of binding was identical for all membrane preparations. In addition, binding to the 45 -kDa band increased in all membranes previously incubated with cholera toxin or the combination of GTP-y-S and Mg`.
In the 36-and 42-45-kDa regions, the intensity of antisera binding appeared to be specific to the membrane preparation. Binding in these regions was substantially higher in membranes prepared from asymptomatic infected animals than in membranes prepared from uninfected animals. Dilfering in quantity only, the binding patterns of the asymptomatic infected and uninfected animals are to be contrasted with those obtained with the symptomatic animals in which substantially less binding occurs in the 36 asymptomatic and symptomatic infected animals failed to reveal substantial inflammatory responses, which are characteristic of the later stages of Chagas' disease. Nonetheless, we determined levels of Na+,K+-ATPase activity as a marker for the purity of our membrane preparation, in both the presence and absence of cholate. As shown in Table 4 , Na+,K+-ATPase activity in myocardial membranes prepared from symptomatic infected animals was significantly higher than the activity determined in membranes prepared from both symptomatic and control animals.
Discussion
Infection of beagle dogs with an opossum-derived strain of T. cruzi results in physiological, pathological, and biochemical consequences consistent with the expression of acute and chronic cardiac dysfunction in the setting of human Chagas' disease.28-31 As we have documented here, conduction abnormalities occur within 20 days after infection, including lengthening of the PR interval. After a brief asymptomatic period, myocardial irritability manifests itself by the presence of frequent ventricular premature contractions and runs of ventricular tachycardia. Complementary ECG data documented myocardial dysfunction early in the chronic stage of disease, again characteristic of the expression of cardiac dysfunction in human Chagas' disease. Similar to observations made in other experimental studies of cardiomyopathy,4,5 we also report a depression of myocardial 83-adrenergic adenylate cyclase activity in symptomatic infected animals. However, in our model, symptomatic animals had no clinically overt evidence of congestive heart failure. Our data are consistent with the hypothesis that l3-adrenergic adenylate cyclase activity is affected early in the progression of cardiac disease before clinically overt symptoms of congestive heart failure develop, and hence suggest a mechanistic relation between early changes in the f8-adrenergic receptor complex and subsequent cardiac dysfunction. In this regard, our results are striking in the degree to which they demarcate the progression of cardiac disease.
In uninfected animals, our results documenting canine myocardial /3-adrenergic receptor density af- flow obstruction model,4 although our data do not permit us to accurately quantify the proportion of highand low-affinity receptors, hence limiting the extent to which the degree of uncoupling can be quantified. Additional evidence implicates a primary abnormality in G, in the symptomatic infected animals. In the current study, as well as in other studies of cardiomyopathy such as the murine model of chagasic cardiomyopathy,6 cholera toxin-dependent ADP-ribosylation was decreased in the symptomatic animal. However, cholera toxin-dependent ADPribosylation can be influenced, in part, by NAD glycohydrolase activity. Thus, only in membranes prepared from infected symptomatic animals, cholera toxin-dependent ADP-ribosylation in response to the presence of NADP, an inhibitor of NAD glycohydrolase activity, was substantially (more than twofold) greater. The influence of NADP was considerably less in both infected asymptomatic and uninfected animals, results similar to the murine model of Chagas' disease.6 This observation suggests that symptomatic infection is associated with a change in the activity of myocardial NAD glycohydrolase. It would be of great interest to determine if altered myocardial NAD glycohydrolase activity occurs in other states of cardiac dysfunction, suggesting an important but as yet to be identified role for the enzyme in myocardial function.
Some limitations in the application of cholera toxin to quantitate Gs have been overcome using antisera directed against the guanine nucleotide binding protein.23 As applied to the developing heart, specific anti-G antisera recognized temporal changes in the expression of the various G proteins. It also is of interest to note that our antisera bind to a number of higher molecular weight proteins not thought to be associated with GQ, whereas in other reports, anti-G, antisera bind predominantly to the 42-52-kDa region. 23 In this regard, polyclonal rabbit antisera raised against various antigens often contain antibodies against keratin, which appears as spurious bands in the molecular weight region greater than 55 kDa.37 The use of affinity-purified Gs antisera (results not shown) did not significantly affect the binding patterns obtained with these membranes. Although preliminary experiments (results not shown) suggest that purification of membranes favors, but does not result in, exclusive antisera binding to the bands of interest, that is, the 42-kDa region, for this study, in the interests of consistency, a uniform membrane preparation was used for all analyses. Central to the concerns of this communication is the striking observation that the influence of infection on the binding of Gas antisera is restricted exclusively to relevant bands of molecular weights less than 45 kDa.
As in all studies of the behavior of the ,3-adrenergic receptor complex in states of myocardial dysfunction, it must be recognized that myocardial membrane preparations contain substantial quantities of membranes from noncardiocyte cell types. Indeed, myocardial dysfunction frequently is associated with varying degrees of inflammation and fibrosis, further contributing to the heterogeneous makeup of the membrane preparation. Our analysis of Na+,K+-ATPase activity indicates that myocardial membranes prepared from symptomatic infected animals actually demonstrate an increase in this activity. This increase in activity occurs only in the setting of infection associated with cardiac dysfunction, implying that it may be specific to myocardial dysfunction and not infection per se. The biochemical basis for this observation has yet to be determined. Nonetheless, by virtue of the extent to which Na+,K+-ATPase activity reflects membrane purity, our data suggest that at this stage of chronic Chagas' disease, the low levels of inflammation observed histologically do not diminish in a demonstrable manner the concentration of myocardial membranes in our preparations. Hence, it would appear unlikely that the decrease in /8-adrenergicmediated adenylate cyclase activity can be accounted for simply by the decrease in the concentration of myocardial membranes in symptomatic infected animals. Moreover, only isoproterenol-dependent adenylate cyclase activity appears to be compromised in cycassays with donor G, from symptomatic infected animals. In contrast, adenylate cyclase activity in response to Gpp(NH)p was uninfluenced by the source of donor Gs. Indeed, the relatively modest decrease4,24 in isoproterenol-associated Gas activity in cyc-assays reported here underscores the notion that the symptomatic infected animals demonstrate scant evidence of cardiac dysfunction, consistent with the minimal pathological changes observed. Similarly, other qualitative changes that are independent of protein concentration attend infection with or without symptomatic myocardial involvement and include patterns of Gas antisera binding, alterations in isoproterenol receptor affinity and influence of Gpp(NH)p, as well as the unique influence of NADP on cholera toxin-dependent ADP-ribosylation. Consistent with our immunochemical and cholera toxin-dependent ADP-ribosylation studies, the adenylate cyclase data may be interpreted as reflecting the possibility that uncoupling of the ,3-adrenergic receptor from the G, protein may be the predominant feature of early changes that antedate cardiac dysfunction in Chagas' disease.
In summary, the infection of dogs with a symptomatic strain of T. cruzi offers the important opportunity to study the development of a cardiomyopathic state wherein subtle indexes of cardiac dysfunction can be accurately assessed and convenient biochemical measurements of ,B-adrenergic receptor activity determined. Our studies suggest that early during the course of cardiac involvement in Chagas' disease, ,B-adrenergic adenylate cyclase activity declines specifically in response to isoproterenol. This probably reflects a functional uncoupling of the /3-adrenergic receptor to the Gs protein, probably as a consequence of an as yet unidentified alteration in Gs. We propose that these early changes in the activity of the ,8-adrenergic receptor complex relate to infectionassociated changes in the microvasculature of the heart, a direct consequence of infection with T. cruzi. 38 The biochemical alterations detailed here may be observed in any pathological state associated with a compromise in microvascular perfusion. sis of Na+,K+-ATPase activity by Drs. Nadim Cortas and Charles Okolo (College of Physicians and Surgeons, Columbia University, New York).
